Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase 1 Study in Patients With HPV+ Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Multiple Cancer Types

This is a multi center, open-label, phase 1 dose escalation and expansion study evaluating the safety, anti-tumor effect, and immunogenicity of CUE-101 in patients with recurrent / metastatic head and neck squamous cell carcinoma (HNSCC).
Head/Neck, Phase I
Gibson, Mike

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: